Brief: Zelira Therapeutics Announces $33 MLN Fundraising Into Zeliras HOPE 1 SPV
16/01/2026 06:22
Jan 16 (Reuters) - Zelira Therapeutics Ltd ZLD.AX: US$33M FUNDRAISING INTO ZELIRAS HOPE 1 SPV Further company coverage: ZLD.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zelira Therapeutics
See all newsBrief: Zelira Therapeutics Announces $33 MLN Fundraising Into Zeliras HOPE 1 SPV
Australia's Zelira Therapeutics surges on $33 million funding for drug trial
Australia's Zelira Therapeutics climbs to over 7-month high on securing patents
Brief: Zelira Therapeutics Receives USD$1.4 Million Unsecured Loan Funds From Chairman
Brief: Zelira Therapeutics Ltd Says Zld Secures Us$1.4M Unsecured Chairman Loan Facility